newsfilter
← Latest News
Business Wire·

GeneDx to Participate in Upcoming Investor Conferences

  • GeneDx (Nasdaq: WGS) announced that company management will participate in two upcoming investor conferences.
  • The 2026 Jefferies Global Healthcare Conference fireside chat is scheduled for Tuesday, November 17 at 4:30 p.m. GMT in London, UK.
  • The Piper Sandler 38th Annual Healthcare Conference fireside chat is scheduled for Wednesday, December 2 at 9:00 a.m. ET in New York City, NY.
  • Live & archived webcasts of the presentations will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events.
  • GeneDx utilizes its GeneDx Infinity™ dataset to power its FDA Breakthrough Device designated ExomeDx™ & GenomeDx™ tests for precise diagnoses.
  • Over the last 25 years, GeneDx has diagnosed more than 4,800 genetic diseases & published more than 1,100 research publications.